Cardiac organoids
Cardiac organoids or cardioid platform uses induced pluripotent stem cells (iPSCs) to create multicellular 3D cardiac tissue that mimics the physiology of a human heart. These cardiac cells self-organize and create chambers similar to a heart, mimicking the human condition in vivo.
HeartBeat.bio brings the biology of cardiac organoids while Molecular Devices has the automation, hardware and imaging capabilities. Together, we work with cardioids and demonstrate how they can be scaled and grown at larger and reproducible volumes to enable cardiotoxicity screens.
- Molecular Devices and HeartBeat.bio announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery
- How cardioids can usher in the next generation of drug discovery
- How 3D Cell Models Will Shape the Future of Drug Discovery
- 3D organoids and automation of complex cell assays [Podcast]